L'Oreal to pay $1.3B for Valeant skin-care brands as drug...

L'Oreal to pay $1.3B for Valeant skin-care brands as drug...


Valeant Pharmaceuticals International Inc., the embattled Canadian drugmaker, agreed to sell about $2.1 billion in assets to get cash to streamline its businesses and begin easing its debt burden. L'Oreal will pay Valeant $1.3 billion for three skin-care brands, the Paris-based company Tuesday said in a statement.



from Biotech News